(Q79291844)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Pharmacokinetics of E5564, a lipopolysaccharide antagonist, in patients with impaired hepatic function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Pharmacokinetics of E5564, a Lipopolysaccharide Antagonist, in Patients with Impaired Hepatic Function (English)

1 reference

https://api.crossref.org/works/10.1177/0091270003258653

1 April 2024

1 reference

1 reference

https://api.crossref.org/works/10.1177/0091270003258653

1 April 2024

1 reference

Earvin Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Irma Allen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Richard Kao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Mark Marino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Clifford DiLea

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Y. Nancy Wong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615472

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14615472

1 April 2024

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 December 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003258653

1 reference

https://api.crossref.org/works/10.1177/0091270003258653

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003258653

1 April 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003258653

The Journal of Clinical Pharmacology

1 April 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1361-1369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615472%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Endotoxemia in human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Polymyxin and Related Peptide Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Detection of circulating tumor necrosis factor after endotoxin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

E5531, a pure endotoxin antagonist of high potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Nitric oxide production and hepatic dysfunction in patients with postoperative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Meningococcemia and acquired complement deficiency. Association in patients with hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Physiological parameters in laboratory animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258653

Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction.

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1177/0091270003258653

Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1177/0091270003258653

Liver dysfunction in critical illness

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1177/0091270003258653